RxDoctor Payments DataLook up a doctor →

Marites Pilapil, APRN

Nurse Practitioner · Henderson, NVNPI 1952752511

Payments from drug & device makers

$11,094in general payments, 2019–2025

Across 586 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Neurocrine Biosciences, Inc.$1K
  • Novartis$628
  • Lundbeck LLC$565
  • UCB, Inc.$537
  • Pfizer$471
  • plus $5K from 43 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)207$3,096
Neurocrine Biosciences, Inc.44$1,288
Novartis55$628
Lundbeck LLC26$565
UCB, Inc.26$537
Pfizer24$471
Teva Pharmaceuticals USA, Inc.24$454
Biogen15$309
Biohaven Pharmaceuticals, Inc.12$308
Amgen(2 entities)14$262
SK Life Science, Inc.10$228
Abbott4$227
Lilly USA, LLC12$201
Acadia Pharmaceuticals Inc11$187
Argenx US, Inc.8$181
EMD Serono, Inc.5$179
AstraZeneca8$163
Ipsen Biopharmaceuticals, Inc7$163
Biohaven Pharmaceutical Holding Company Ltd.8$158
Amneal Pharmaceuticals LLC9$152
Sanofi5$137
E.r. Squibb & Sons, L.L.C.1$104
Sunovion Pharmaceuticals Inc.5$91
Eisai Inc.3$75
Kyowa Kirin, Inc.4$72
Upsher-smith Laboratories LLC4$71
Jazz Pharmaceuticals Inc.2$65
Inspire Medical Systems, Inc.1$61
Otsuka America Pharmaceutical, Inc.2$54
Sanofi-aventis U.S. LLC3$53
Avanir Pharmaceuticals, Inc.3$50
Bristol Myers Squibb3$47
Sumitomo Pharma America, Inc.2$47
Grifols USA, LLC2$44
Merz Pharmaceuticals, LLC1$38
Medtronic2$36
Johnson & Johnson1$32
ANI Pharmaceuticals, Inc.1$31
Avion Pharmaceuticals1$28
Alnylam Pharmaceuticals Inc.1$28
Harmony Biosciences LLC1$27
Acorda Therapeutics, Inc2$25
Sonex Health, Inc.1$24
Genentech USA, Inc.1$19
GRT US Holding, Inc.1$18
Banner Life Sciences, LLC1$18
Adamas Pharmaceuticals, Inc.1$17
Tanabe Pharma America, Inc.1$14
Axsome Therapeutics, Inc.1$14

How this compares

$11,094 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.

See all nurse practitioner providers in Nevada →

Medicare billing

Part B allowed, 2024
$47,929
Medicare patients
342
Services billed
528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Henderson

See the full list for Nevada →

Where these figures come from

Is this you, or does something look wrong? →